Centre for Oncopathology (COP) is a specialist oncopathology reference laboratory in Mumbai, providing precise cancer diagnostics through histopathology, cytology, immunohistochemistry, molecular pathology and allied services.
As a unit of Tata Cancer Care Foundation (TCCF) COP brings together trusted expertise and a non-profit purpose to expand access to high-quality, reliable and timely cancer diagnostics across India.
Bringing Diagnostic Certainty and Clarity
Cancer treatment decisions begin with the right diagnosis. COP exists to support clinicians and institutions with specialised oncopathology, advanced biomarker testing, and expert-led interpretation, especially for complex and challenging cases.
How COP Works
Advancing Accurate Diagnosis
Advanced diagnostics across histopathology and molecular pathology, supported by IHC, FISH and molecular labs.
Impeccable Infrastructure
State-of-the-art technology and systems designed for precision and consistency.
Academic Excellence
A strong academic focus through fellowships and training programmes that build oncopathology capacity.
Clinical Expertise
Expertise in second opinions on complex cases, with referrals from India and overseas.
The Vision That Led Us Here
Knowledge must circulate, standards must stay high, and learning must never stop.
COP was envisioned and led by late Dr Anita Borges, a renowned oncopathologist and former Professor and Head of Surgical Pathology at Tata Memorial Hospital.
She built COP around a simple, uncompromising principle: diagnostic quality must always be patient-first.
Partners and Collaborators
India’s Rising Cancer Burden
As per Cancer India and the Indian Council of Medical Research – National Cancer Registry Programme, cancer incidence in India has been rising steadily, with an estimated 1.46–1.5 million new cases reported annually, and projections indicating continued growth in the years ahead. It is estimated that one in nine Indians could develop cancer in their lifetime, with the overall burden expected to increase significantly due to population growth and ageing.
Join Us in Advancing Cancer Care
A PubMed Central study further notes that these figures represent diagnosed cases, and the actual numbers are likely higher—pointing to a growing national health concern. Despite this rising burden, access to timely and quality cancer care remains uneven across the country. Low awareness, delayed detection, and limited access to diagnostic and treatment facilities continue to affect outcomes.
The Gap
These challenges are compounded by gaps in infrastructure, a shortage of trained healthcare professionals, and the high cost of care, often forcing patients to travel long distances for treatment. The imbalance between early and late-stage detection highlights the need for earlier and more accurate diagnosis.
This growing gap underscores the need for accessible, high-quality cancer diagnostic infrastructure across India—one that enables early detection, improves diagnostic accuracy, and brings specialised care closer to patients through a more distributed and patient-centric model of cancer care.
Have a query?
Reach out to us and we will guide you to the right support.
